COMPETENCE Trial: The EVAHEART 2 continuous flow left ventricular assist device.
Allen SR, Slaughter MS, Ahmed MM, Bartoli CR, Dhingra R, Egnaczyk GF, Gulati SK, Kiernan MS, Mahr C, Meyer DM, Motomura T, Ono M, Ravichandran A, Shafii A, Smith J, Soleimani B, Toyoda Y, Yarboro LT, Dowling RD.
Allen SR, et al. Among authors: gulati sk.
J Heart Lung Transplant. 2023 Jan;42(1):33-39. doi: 10.1016/j.healun.2022.10.011. Epub 2022 Oct 19.
J Heart Lung Transplant. 2023.
PMID: 36347767
Clinical Trial.
Enrollment of a safety cohort is projected to be completed by third quarter of 2022 at which time an interim analysis will be performed. Short-term cohort (92 EVA2 subjects) and long-term cohort is expected to be completed by the end of 2023 and 2024, respectively. …
Enrollment of a safety cohort is projected to be completed by third quarter of 2022 at which time an interim analysis will be performed. Sho …